References
- Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni l, Ganguli M, et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005; 366: 2112–2117
- Howard R, Ballard C, O'Brien J, Burns A. UK and Ireland Group for Optimization of Management in dementia. Guidelines for the management of agitation in dementia. International Journal of Geriatric Psychiatry 2001; 16: 714–717
- Kales HC, Chen P, Blow FC, Welsh DE, Mellow AM. Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression. American Journal of Geriatric Psychiatry 2005; 13: 441–449
- Lyketsos CG. Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. International Psychogeriatrics 2006; 19: 409–420
- O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni I, et al. Vascular cognitive impairment. Lancet Neurology 2003; 2: 89–98
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kolmen E. Mild cognitive impairment: Clinical characterization and outcome. Archives of Neurology 1999; 56: 303–308
- Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?. Journal of Neurology, Neurosurgery & Psychiatry 2000; 69: 308–312
- Schweitzer I, Tuckwell V, O'Brien J, Ames D. Is late onset depression a prodrome to dementia?. International Journal of Geriatric Psychiatry 2002; 17: 997–1005
- Verheijen J, Huisman L, van Lent N, et al. Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay. Clinical Chemistry 2006; 52: 1168–1174